Stock Market Today, Oct. 26: Surgery Partners Skyrockets 48% on $5.7 Billion HealthSpan Acquisition

SGRY jumped 48% after HealthSpan Partners announced a $5.7 billion all-cash acquisition at $23.50 per share. The stock now trades just below that offer price, a sign the market is pricing in a high probability the deal closes.

Completion is expected in Q1 2027. That timeline leaves SGRY holders with a long runway between today's price and the final payout. The narrow gap between the current quote and $23.50 is the market's implied estimate of that time value and completion risk. This is interpretation of the pricing, not additional deal information.

The valuation also looks favorable for the buyer. SGRY shares sit near levels from a year ago, which makes the 48% pop less a re-rating than a recovery to prior territory. That framing suggests HealthSpan Partners is acquiring at a price that doesn't stretch far beyond where the stock recently traded, an interpretation based on the one-year comparison.

An all-cash structure removes exchange-ratio and acquirer-stock risk, leaving the main variables as timing and closing conditions. No competing bid is referenced in the available details, so the $23.50 figure currently functions as the ceiling for the stock.